A Seattle-based company with an objective of accelerating progress in human health and scientific research recently announced a partnership to distribute a variety of Transcriptome and fixation kits to Singapore and Southeast Asia markets.
The collaboration will bring together Parse Biosciences and Research Instruments Pte Ltd. to offer Parse’s Evercode Whole Transcriptome Kits (WTKs), Cell Fixation Kits and Nuclei Fixation Kits to those markets, according to a press release published by Business Wire.
Alex Rosenberg. CEO and co-founder of Parse Biosciences said the company is ecstatic about the collaboration and looks forward to serving Southeast Asian markets.
“A significant priority for the Parse team is accessibility–not only in how readily customers can start using the technology, but also with a fully supportive team backing their efforts,” Rosenberg said in the release. “We’re thrilled that Research Instruments shares our vision of offering scalable and easily adaptable single-cell RNA-seq technology to a wide market.”
The deal will ensure supply distributions to Singapore, Thailand, Malaysia and Vietnam, the release stated.
Research Instruments is the leading genomic and life science research distributor in the region with numerous technical teams and customer support relationships, according to the release.
“At RI, we’re committed to providing access to innovative technologies,” Greg Kent, CEO of Research Instruments, said in the release. “The sequencing solutions of Parse Biosciences simplify workflows without sacrificing resolution, and with our technical sales and applications support teams who are trained and experienced in single cell genomics applications, the Parse Bioscience platform now becomes readily accessible to any scientist in the region.”